GLP-1 receptor agonists like semaglutide and tirzepatide have transformed the landscape of medical weight loss and type 2 diabetes management. Originally designed to regulate blood sugar and reduce cardiovascular risk in patients with diabetes, these medications also help suppress appetite, promote satiety, and reduce body fat—making them one of the most effective tools for sustainable … Continue reading Microdosing GLP-1 Medications: A Smarter, Gentler Approach to Metabolic Health